Developing a nanotechnology-enabled glaucoma device

VisiPlate is designed to treat open-angle glaucoma
VisiPlate is an investigational implant designed to lower intraocular pressure in patients with open-angle glaucoma
Avisi in the news

Avisi Technologies Thought Leadership Impact at LSI US ’25
Recap of Avisi CEO’s Participation in Two Impactful Panels at LSI Emerging Medtech Summit Avisi Technologies returns to the Life Science Intelligence (LSI) stage with CEO Rui Jing Jiang participating in several panel discussions at the 2025 MedTech Summit. The panel discussions involved leadership and design strategies for achieving success within the MedTech industry. Life […]

Ultrathin Shunt Shows Promising Results in Trial
In an article by Glaucoma Physician, Jim Gallagher reports on the positive six-month results for VisiPlate® from the VITA trial presented by Dr. Eydie Miller-Ellis at the American Glaucoma Society (AGS). This was considered a top paper by the society and presented during the Surgery Day Paper Presentation at AGS. Dr. Miller-Ellis serves as the […]

Next-Gen Avisi Technologies Aims for “One and Done” in a MIGS Device
Some medtech start-ups begin with an inventor with a novel idea; others seek out an unmet clinical need looking for a solution. Avisi Technologies began with market research, that is, a direct appeal to glaucoma specialists to determine what they were missing in their tool kits, and specifically, how the current generation of devices for minimally invasive […]